AI Article Synopsis

  • - Neonatal lupus erythematosus (NLE) is an autoimmune condition that leads to a red rash around the eyes in newborns.
  • - It can result in post-inflammatory hypopigmentation (lightening of the skin) and telangiectasias (small dilated blood vessels), which might be more visible in infants with darker skin.
  • - The article describes two infants with darker skin tones, where these skin changes helped in diagnosing NLE.

Article Abstract

Neonatal lupus erythematosus (NLE) is an autoimmune disease characterized by a periorbital erythematous rash. Although post-inflammatory hypopigmentation and telangiectasias are known possible sequelae, these features may be particularly noticeable in skin of color. Herein, we describe two infants with skin of color in whom periorbital hypopigmentation and telangiectasias were clues to the diagnosis of NLE.

Download full-text PDF

Source
http://dx.doi.org/10.1111/pde.14674DOI Listing

Publication Analysis

Top Keywords

hypopigmentation telangiectasias
12
skin color
12
periorbital hypopigmentation
8
telangiectasias clues
8
neonatal lupus
8
clues diagnosing
4
diagnosing neonatal
4
lupus skin
4
color neonatal
4
lupus erythematosus
4

Similar Publications

Article Synopsis
  • Facial photoaging, mainly caused by UV radiation, leads to various skin issues like hyperpigmentation, wrinkles, and enlarged pores, prompting the need for effective treatments.
  • This study examined the effects of treating 20 Chinese women with a combination of picosecond alexandrite laser (PSAL) and long-pulse alexandrite laser (LPAL) over three sessions, assessing both the skin's condition and patient satisfaction.
  • Results showed significant improvements in multiple skin indices, high patient satisfaction (average score of 4.67), and no severe side effects, indicating that this combined laser treatment is both effective and safe for addressing facial photoaging.
View Article and Find Full Text PDF

Intralesional steroids commonly used for keloid treatment have adverse effects like cutaneous atrophy and telangiectasias. Safer and more effective therapies are needed. Preliminary studies suggest intralesional vitamin D as a potential alternative treatment.

View Article and Find Full Text PDF
Article Synopsis
  • Addressing hypertrophic scars and keloids is challenging, and this study aims to evaluate the effectiveness and safety of combining corticosteroids with 5-fluorouracil (5-FU) for treatment.
  • A systematic search identified 15 studies, showing that the combined treatment group had significantly better outcomes in terms of scar height and patient assessments compared to the control group, despite no major differences in scar vascularity, pliability, and pigmentation.
  • The results indicate that the corticosteroid and 5-FU combination is a more effective treatment option with fewer side effects, providing a promising strategy for managing these types of scars.
View Article and Find Full Text PDF

Smart Use of Skin Biopsy Punch in Treating Keloids: A Single-Center Retrospective Study.

Aesthetic Plast Surg

August 2024

Department of Dermatologic Surgery and Dermatologic Oncology, Dermatology Hospital of Southern Medical University, Guangdong Provincial Dermatology Hospital, 2 Lujing Road, Yuexiu District, Guangzhou, 510000, Guangdong Province, China.

Background: Treatment of scarring has long been a problem due to high incidence and recurrence. Despite many existing treatment therapies, the efficacy remains unstable.

Objectives: To determine the efficacy and safety of skin biopsy punch in combination with corticosteroid injection (BPCI) in treating keloids.

View Article and Find Full Text PDF

Nonsteroidal Approaches for Atopic Dermatitis®: A Clinical Update.

Dermatitis

November 2024

Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Topical corticosteroids (TCSs) are the most widely used treatment for atopic Dermatitis® (AD), but they can have adverse effects such as skin atrophy, telangiectasias, and hypopigmentation, especially with prolonged use of higher potency steroids. Many patients also have a fear of using TCSs, known as "corticophobia." With the development of biologics and Janus kinase inhibitors, a nonsteroidal approach to the treatment of AD may be possible and may be preferred by certain patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!